Navigation Links
Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis

ere adjudicated by a blinded, independent central adjudication committee. The study was not powered to show a dose response with PRT054021 or efficacy of PRT054021 versus enoxaparin.

About PRT054021 -- Portola's Factor Xa Inhibitor

PRT054021 is an oral Factor Xa inhibitor, an anticoagulant initially being studied for the prevention of venous thromboembolism in patients who have undergone orthopedic surgery. Portola expects to develop PRT054021 for additional indications including stroke prevention in patients with atrial fibrillation and secondary prevention of myocardial infarction and stroke. Factor Xa is a validated target (one for which there are approved drugs on the market), and inhibiting its activity is believed to have superior anticoagulant properties compared to other targets such as thrombin. Portola believes its oral Factor Xa inhibitor will offer several advantages, including a twenty hour pharmacodynamic half-life to support once daily dosing and a low peak-to-trough concentration ratio, resulting in consistent activity that does not require monitoring or dose adjustment. In addition, PRT054021 is not excreted in the kidneys and therefore will not require dose adjustment in patients with impaired renal function. PRT054021 is expected to enter Phase III clinical development in the first half of 2008.

About Portola Pharmaceuticals, Inc.

Portola Pharmaceuticals, Inc. is a privately-held biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapeutics for acute and chronic cardiovascular and vascular disease. Portola is currently developing two clinical stage antithrombotics. Portola's lead compound, PRT054021, is an oral Factor Xa inhibitor for the prevention of venous thromboembolism after orthopedic surgery, for stroke prevention in patients with atrial fibrillation and for secondary prevention of myocardial infarction (MI) and stroke. Portola's second compound, PRT060128, is an o
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
2. Portola Pharmaceuticals Announces Positive Phase II Results for PRT054021 for Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery
3. Portola Pharmaceuticals Presents Positive Phase I Data of Its ADP Receptor Antagonist at the American College of Cardiology
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
Post Your Comments:
(Date:5/17/2013)... , May 17, 2013  ConvaTec today announced that it will report ... Ken Berger , CEO, and Ed Borkowski , ... live via telephone. To participate in the conference call ... To participate in the conference call outside the U.S. and ... conference ID is 72195398. Participants should dial in 10 minutes ...
(Date:5/17/2013)... Fla. , May 17, 2013 Fuse Science, ... delivery technology company that is developing new, patent-pending technologies poised ... announced today that it will hold a business update teleconference ... May 22 nd , 2013 at 4:30 PM ET. ... will host the call and will be joined ...
(Date:5/17/2013)...  Atossa Genetics, Inc. (NASDAQ: ATOS ), The ... , Chief Financial Officer & General Counsel, will present ... May 30, 2013, in New York City ... Company,s presentation is scheduled to begin at 3:30 p.m. EDT ... the webcast, go to www.atossagenetics.com . For ...
Breaking Medicine Technology:Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3
... May 27, 2011 CVS Caremark Corporation (NYSE: ... awarded a three-year contract to provide integrated pharmacy benefit ... Service Benefit Plan, also known as the Federal Employee ... Company will continue to provide FEP,s clinical programs and ...
... Kluwer Health today announced that it has completed the ... information and clinical content for pharmacists, clinicians and hospitals ... of strategic acquisitions Wolters Kluwer Health has made in ... strong focus on the point-of-care market. ...
Cached Medicine Technology:CVS Caremark Awarded Integrated 3-Year Blue Cross and Blue Shield Federal Employee Program (FEP) Contract 2Wolters Kluwer Health Completes Acquisition of Lexi-Comp, Inc. 2Wolters Kluwer Health Completes Acquisition of Lexi-Comp, Inc. 3
(Date:5/19/2013)... Alonso Krangle LLP a dedicated law firm , ... on behalf of a-24-year-old financial analyst rendered quadriplegic as a ... accident lawsuit, which was filed in the Supreme Court for ... the property out as a bathing beach, but posted absolutely ... No. 34556/12) , According to the diving accident lawsuit complaint, ...
(Date:5/19/2013)... Seven-year-old Torin Phillips and his 6-year-old sister, Kaia, ... of autism. The two siblings, who live just outside ... therapy (ABA) from the Center for Autism and ... effective treatment centers using evidence-based, state-of-the-art therapy. , At ... answer to his name, and had little interest in ...
(Date:5/19/2013)... May 19, 2013 Daily Gossip reporters have ... 17 Cheat Foods That Burn Fat to a close ... , The review is a detailed explanation ... the writer's recommendation. , The two nutritionists have discovered during ... responsible for the caloric intake and expenditure of our body, ...
(Date:5/19/2013)... GA (PRWEB) May 19, 2013 ... the National Council of Asian Pacific Physicians (NCAPIP), ... of the National Association of Chronic Disease Directors ... status of health systems, diabetes, and non-communicable diseases ... , The assessment, published in the Hawaii Journal ...
(Date:5/19/2013)... Although spring arrived late this year in parts of ... be strong, according to a sinus expert at the ... clinical professor in the university,s division of otolaryngology, said ... allergy season. However, some simple strategies can help people ... added. "Tree pollen has been bad for several ...
Breaking Medicine News(10 mins):Health News:Alonso Krangle Files Diving Accident Lawsuit on Behalf of Suffolk County Man Rendered Quadraplegic in Tragic Diving Accident at Long Island Beach 2Health News:Alonso Krangle Files Diving Accident Lawsuit on Behalf of Suffolk County Man Rendered Quadraplegic in Tragic Diving Accident at Long Island Beach 3Health News:Boston Brother and Sister Battle Odds to Overcome Autism with Help from Center for Autism and Related Disorders 2Health News:Boston Brother and Sister Battle Odds to Overcome Autism with Help from Center for Autism and Related Disorders 3Health News:Boston Brother and Sister Battle Odds to Overcome Autism with Help from Center for Autism and Related Disorders 4Health News:The "17 Cheat Foods That Burn Fat" Review and Diet Plan Secrets Revealed by Daily Gossip 2Health News:Pacific Island Public Health Group Declares Diabetes at Pandemic Proportions 2Health News:Pacific Island Public Health Group Declares Diabetes at Pandemic Proportions 3Health News:Managing Seasonal Allergies 2
... replacement care, according to Dr. Xueya Cai and colleagues ... work, published online in Springer,s journal Clinical Orthopaedics and ... likely than Caucasians to receive total knee arthroplasty (or ... is widely performed in patients of all races with ...
... , TUESDAY, Sept. 13 (HealthDay News) --,Two decades after the ... abnormalities in their brains that in some cases have even ... part of a debilitating disorder known as Gulf War illness. ... to be caused by exposure to neurotoxins and nerve gas. ...
... study finds that infections following cardiac device implantations or ... in terms of patient mortality, even months after affected ... led to 4.8 to 7.7-fold increases in admission mortality, ... 4.0-fold increases in hospital length of stay, and 1.4 ...
... Chicago Many patients are responding to a new, ... out the bad cells. Atrial fibrillation (A-Fib) is one ... arrhythmia affecting Americans. However, new research shows that 70 ... with cryoballoon ablation, the freezing technique, are free of ...
... Steele HealthDay Reporter , MONDAY, Sept. 12 ... help people with mild memory problems or early Alzheimer,s ... small study suggests. But, the study authors added, ... therapy will actually benefit patients. Alzheimer,s disease, the ...
... WINSTON-SALEM, N.C. September 12, 2011 A year ... listening to doctor,s orders when it comes to taking ... of Wake Forest Baptist Medical Center shows. However, there ... "Medication non-compliance is a major risk factor for stroke ...
Cached Medicine News:Health News:Does race dictate quality of care? 2Health News:Brain Blood Flow Abnormalities Persist in Gulf War Vets 2Health News:Costs, mortality skyrocket following infection in cardiac device recipients 2Health News:Freeze and desist: Disabling cardiac cells that can cause arrhythmia 2Health News:Insulin Spray May Improve Alzheimer's Symptoms 2Health News:Insulin Spray May Improve Alzheimer's Symptoms 3Health News:Researchers focus on secondary stroke prevention after study reveals room for improvement 2Health News:Researchers focus on secondary stroke prevention after study reveals room for improvement 3Health News:Researchers focus on secondary stroke prevention after study reveals room for improvement 4
... evanescent wave imaging system utilizes an ... in the thin section in contact ... This unique design permits simultaneous mounting ... systems, with no restriction on their ...
... color imaging camera system designed for ... performance, megapixel digital cameras provides high-resolution, ... them on a PC via its ... "live" previewing capability is accompanied by ...
... Tech GT-Capture digital camera photomicrographic system can ... such as Olympus, Leica, Nikon, and Zeiss, ... transferring images over the Internet easy and ... a performance-proven Nikkor lens. The system records ...
... Digital camera systems for optimum image quality ... low light, color digital camera system is ... light is available. State-of-the-art electronics create bright, ... The high dynamic range offered by the ...
Medicine Products: